Company Overview of AmpliMed Corporation
AmpliMed Corporation focuses on the development of small-molecule oncology drugs. Its products include Amplimexon, a small molecule that causes cancer cells to stop dividing and ultimately to die; Amplizone that has demonstrated efficacy in the treatment of solid tumors in animal tumor models; and benzimidazole Series: benzimidazole analog small molecules that expressed tubulin binding activity in yeast and mammalian cells. The company’s products are used to treat pancreatic cancer, lung cancer, malignant melanoma, ovarian cancer, and multiple myeloma. AmpliMed Corporation was founded in 1989 and is based in Tucson, Arizona.
4380 North Campbell Avenue
Tucson, AZ 85718
Founded in 1989
Key Executives for AmpliMed Corporation
Similar Private Companies By Industry
|BN ImmunoTherapeutics Inc.||United States|
|Oncology Research Therapeutics||United States|
|InVite Health, Inc.||United States|
|Zeneca Wilmington Inc.||United States|
|BioActives LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact AmpliMed Corporation, please visit www.amplimed.com. Company data is provided by Capital IQ. Please use this form to report any data issues.